SK6452003A3 - Antidiabetic compositions containing a biguanide and a sulfonamide - Google Patents

Antidiabetic compositions containing a biguanide and a sulfonamide Download PDF

Info

Publication number
SK6452003A3
SK6452003A3 SK645-2003A SK6452003A SK6452003A3 SK 6452003 A3 SK6452003 A3 SK 6452003A3 SK 6452003 A SK6452003 A SK 6452003A SK 6452003 A3 SK6452003 A3 SK 6452003A3
Authority
SK
Slovakia
Prior art keywords
sulfonamide
biguanide
combination
pharmaceutical composition
glibenclamide
Prior art date
Application number
SK645-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Nathalie Cugnardey
Nicolas Wiernsperger
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK6452003A3 publication Critical patent/SK6452003A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SK645-2003A 2000-11-22 2001-10-29 Antidiabetic compositions containing a biguanide and a sulfonamide SK6452003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0015066A FR2816841B1 (fr) 2000-11-22 2000-11-22 Nouvelles compositions pharmaceutiques a action antidiabetique et leur procede de preparation
PCT/EP2001/012492 WO2002041879A2 (en) 2000-11-22 2001-10-29 Antidiabetic compositions containing a biguanide and a sulfonamide

Publications (1)

Publication Number Publication Date
SK6452003A3 true SK6452003A3 (en) 2003-09-11

Family

ID=8856750

Family Applications (1)

Application Number Title Priority Date Filing Date
SK645-2003A SK6452003A3 (en) 2000-11-22 2001-10-29 Antidiabetic compositions containing a biguanide and a sulfonamide

Country Status (18)

Country Link
US (1) US20040039031A1 (hu)
EP (1) EP1335731A2 (hu)
JP (1) JP2004513962A (hu)
KR (1) KR20030051858A (hu)
CN (1) CN1474696A (hu)
AU (2) AU2002221779A1 (hu)
BR (1) BR0115506A (hu)
CA (1) CA2429257A1 (hu)
CZ (1) CZ20031449A3 (hu)
FR (1) FR2816841B1 (hu)
HU (1) HUP0302620A3 (hu)
MX (1) MXPA03004431A (hu)
NO (1) NO20032287L (hu)
PL (1) PL361189A1 (hu)
RU (1) RU2003116890A (hu)
SK (1) SK6452003A3 (hu)
WO (2) WO2002041879A2 (hu)
ZA (1) ZA200304766B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911781B2 (en) 2002-06-17 2014-12-16 Inventia Healthcare Private Limited Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides
WO2005117855A1 (ja) * 2004-06-04 2005-12-15 Kowa Company., Ltd. 糖尿病の予防または治療のための薬剤
WO2007105730A1 (ja) * 2006-03-13 2007-09-20 Kyowa Hakko Kogyo Co., Ltd. インスリン抵抗性改善剤
PL2106260T3 (pl) 2007-01-25 2018-06-29 NAIA Metabolic, Inc. Środki uwrażliwiające na insulinę i sposoby leczenia
EP2273989A4 (en) * 2008-04-07 2013-05-01 Interface Biologics Inc POLYTHERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2347531A1 (de) * 1973-09-21 1975-04-30 Hoechst Ag Arzneizubereitungen zur oralen diabetes-behandlung
IT1276130B1 (it) * 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
JP4278863B2 (ja) * 1997-12-08 2009-06-17 ブリストル−マイヤーズ スクイブ カンパニー メトホルミンの新規塩および方法
SI0974356T1 (en) * 1998-07-15 2003-12-31 Merck Sante Tablets comprising a combination of metformin and glibenclamide

Also Published As

Publication number Publication date
CA2429257A1 (en) 2002-05-30
NO20032287D0 (no) 2003-05-21
MXPA03004431A (es) 2003-08-19
FR2816841B1 (fr) 2004-02-06
WO2002041879A3 (en) 2003-05-22
HUP0302620A3 (en) 2005-06-28
NO20032287L (no) 2003-05-21
EP1335731A2 (en) 2003-08-20
JP2004513962A (ja) 2004-05-13
AU2002221779A1 (en) 2002-06-03
BR0115506A (pt) 2003-10-21
AU2002222026A1 (en) 2002-06-03
US20040039031A1 (en) 2004-02-26
FR2816841A1 (fr) 2002-05-24
CZ20031449A3 (cs) 2003-09-17
HUP0302620A2 (hu) 2003-11-28
WO2002041897A2 (fr) 2002-05-30
RU2003116890A (ru) 2004-12-10
PL361189A1 (en) 2004-09-20
WO2002041879A2 (en) 2002-05-30
KR20030051858A (ko) 2003-06-25
CN1474696A (zh) 2004-02-11
WO2002041897A3 (fr) 2003-05-30
ZA200304766B (en) 2004-09-20

Similar Documents

Publication Publication Date Title
US8034799B2 (en) Preventing and/or treating cardiovascular disease and/or associated heart failure
EP1303304B1 (en) Pharmaceutical combinations for treatment and prevention of diabetes mellitus
EP1267850B1 (en) Use of insulin sensitivity increasing substances for the treatment of alopecia
EP0128483B1 (de) Neue galenische Zubereitungsformen von oralen Antidiabetika und Verfahren zu ihrer Herstellung
EP1471902B1 (en) Compositions for use in methods for treating hearing loss
LT5025B (lt) Mažos dozės priešdiabetinė farmacinė kompozicija
DE19823831A1 (de) Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
HRP970505A2 (en) Method of medical treatment
KR20010015890A (ko) 신경변성질환 치료약
SK287810B6 (sk) Farmaceutický prostriedok obsahujúci nízkodávkovú kombináciu metformínu a glyburidu
WO2004017957A1 (en) Preventing and/or treating cardiovascular disease and/or associated heart failure
SK6452003A3 (en) Antidiabetic compositions containing a biguanide and a sulfonamide
EP1033129B1 (en) Antimicrobials for treating peptic ulcer
US4153710A (en) N-(4-[2-(pyrazole-1-carbonamide)-ethyl]-benzenesulphonyl)-urea
EP1857118A1 (en) Medicinal composition for treating diabetes
EP0397646A1 (de) Pharmazeutisches Präparat zur Behandlung von Lebererkrankungen
EA001673B1 (ru) Применение ингибиторов катехол-о-метилтрансферазы (комт) для производства лекарственного средства для профилактики сосудистых дисфункций при диабете
EP2001555A1 (de) Verwendung von strobilurinen zur behandlung von störungen des eisen-stoffwechsels
EP0868176B1 (en) Aminoguanidine for treating niddm
US20010025053A1 (en) Use of nitric oxid synthase inhibitors for the treatment of diabetes
JP2000502668A (ja) Ｉｉ型糖尿病の治療または予防のための一酸化窒素（ｎｏ）シンターゼ阻害剤
WO1998035667A1 (en) Use of nitric oxid synthase inhibitors for the treatment of diabetes
JPS61103831A (ja) 抗寄生原虫剤
WO2003045387A1 (en) Pharmaceutical composition with combined active agents containing metformin and a hydroxylamine derivative